Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fabre J., Fox H. M., Dayer P., Balant L. Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents. Clin Pharmacokinet. 1980 Sep-Oct;5(5):441–464. doi: 10.2165/00003088-198005050-00003. [DOI] [PubMed] [Google Scholar]
- Morselli P. L., Franco-Morselli R., Bossi L. Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clin Pharmacokinet. 1980 Nov-Dec;5(6):485–527. doi: 10.2165/00003088-198005060-00001. [DOI] [PubMed] [Google Scholar]
- Riddell J. G., Neill J. D., Kelly J. G., McDevitt D. G. Effects of thyroid dysfunction on propranolol kinetics. Clin Pharmacol Ther. 1980 Nov;28(5):565–574. doi: 10.1038/clpt.1980.204. [DOI] [PubMed] [Google Scholar]
- Vestal R. E. Drug use in the elderly: a review of problems and special considerations. Drugs. 1978 Oct;16(4):358–382. doi: 10.2165/00003495-197816040-00004. [DOI] [PubMed] [Google Scholar]
- Williams R. L., Mamelok R. D. Hepatic disease and drug pharmacokinetics. Clin Pharmacokinet. 1980 Nov-Dec;5(6):528–547. doi: 10.2165/00003088-198005060-00002. [DOI] [PubMed] [Google Scholar]
- Wood A. J., Kornhauser D. M., Wilkinson G. R., Shand D. G., Branch R. A. The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration. Clin Pharmacokinet. 1978 Nov-Dec;3(6):478–487. doi: 10.2165/00003088-197803060-00005. [DOI] [PubMed] [Google Scholar]